Literature DB >> 15579743

A novel circulating hormone of testis origin in humans.

Carlo Foresta1, Andrea Bettella, Cinzia Vinanzi, Paolo Dabrilli, Maria Cristina Meriggiola, Andrea Garolla, Alberto Ferlin.   

Abstract

Insulin-like factor 3 (INSL3) is a member of the relaxin-insulin family, and it is expressed in pre- and postnatal Leydig cells of the testis. This peptide affects testicular descent during embryonic development, and mutations in INSL3 gene or its receptor LGR8 (leucine-rich repeat-containing G protein-coupled receptor 8)/GREAT (G protein-coupled receptor affecting testicular descent) cause cryptorchidism in humans. The expression of LGR8/GREAT in different tissues and the production of INSL3 also by adult-type Leydig cells suggest additional roles of this hormonal system in adulthood. In this preliminary report we performed the first analysis in humans of INSL3 using a novel RIA kit to measure INSL3 concentrations in serum of normal men and with different testicular pathologies. The results show that INSL3 is circulating in adult men, and it is almost exclusively of testicular origin. Subjects with severe testicular damage, such as men with severe infertility, produce low amount of INSL3, and the concentrations of this hormone seem to reflect the functional status of the Leydig cells. In particular, INSL3 concentrations may be an even more sensitive marker of Leydig cell function than testosterone itself. Analysis of men treated with different combinations of hormones of the hypothalamus-pituitary-testis axis suggests that the production of INSL3 is related to LH in a manner similar to that of the LH-testosterone axis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579743     DOI: 10.1210/jc.2004-0575

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Serum insulin-like factor 3 quantification by LC-MS/MS in male patients with hypogonadotropic hypogonadism and Klinefelter syndrome.

Authors:  Trine Holm Johannsen; Marie Lindhardt Ljubicic; Jacques Young; Séverine Trabado; Jørgen Holm Petersen; Allan Linneberg; Jakob Albrethsen; Anders Juul
Journal:  Endocrine       Date:  2021-01-22       Impact factor: 3.633

Review 2.  Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside.

Authors:  Alberto Ferlin; Luca De Toni; Marco Sandri; Carlo Foresta
Journal:  Br J Pharmacol       Date:  2016-05-05       Impact factor: 8.739

Review 3.  Consensus statement on diagnosis and clinical management of Klinefelter syndrome.

Authors:  A F Radicioni; A Ferlin; G Balercia; D Pasquali; L Vignozzi; M Maggi; C Foresta; A Lenzi
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

4.  Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment.

Authors:  Marco Rossato; Francesca Dassie; Valentina Silvestrin; Chiara Martini; Roberto Vettor; Pietro Maffei
Journal:  Endocrine       Date:  2014-06-12       Impact factor: 3.633

Review 5.  Relaxin family peptide systems and the central nervous system.

Authors:  G E Callander; R A D Bathgate
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

Review 6.  The gonadal function in obese adolescents: review.

Authors:  Rosita A Condorelli; Aldo E Calogero; Enzo Vicari; Laura Mongioi'; Vincenzo Favilla; Giuseppe Morgia; Sebastiano Cimino; Giorgio Russo; Sandro La Vignera
Journal:  J Endocrinol Invest       Date:  2014-06-13       Impact factor: 4.256

Review 7.  Testicular function and bone metabolism--beyond testosterone.

Authors:  Alberto Ferlin; Riccardo Selice; Umberto Carraro; Carlo Foresta
Journal:  Nat Rev Endocrinol       Date:  2013-07-16       Impact factor: 43.330

Review 8.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

9.  INSL3 in the ruminant: a powerful indicator of gender- and genetic-specific feto-maternal dialogue.

Authors:  Ravinder Anand-Ivell; Stefan Hiendleder; Carolina Viñoles; Graeme B Martin; Carolyn Fitzsimmons; Andrea Eurich; Bettina Hafen; Richard Ivell
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

10.  Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial.

Authors:  Mara Y Roth; Kat Lin; Katrine Bay; John K Amory; Bradley D Anawalt; Alvin M Matsumoto; Brett T Marck; William J Bremner; Stephanie T Page
Journal:  Fertil Steril       Date:  2012-10-03       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.